Five-Year Outcomes Of The Registry To Evaluate Early And Long-Term Pulmonary Arterial Hypertension (pah) Disease Management (reveal)

被引：0
|
作者：
Miller, D. P. [1 ,2 ]
Farber, H. W. [2 ]
Poms, A. M. [3 ]
Badesch, D. B. [4 ]
Muros-Le Rouzic, E. [5 ]
Benton, W. [6 ]
McGoon, M. D. [7 ]
机构：
[1] ICON Clin Res, San Francisco, CA USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA
[5] Actel Pharmaceut, Allschwil, Switzerland
[6] Actel Pharmaceut US Inc, San Francisco, CA USA
[7] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4741
引用
收藏
页数：3
相关论文
共 50 条
  • [11] The REVEAL registry: a tool for the evaluation of early and long-term PAH disease management
    Barst, R. J.
    Mcgoon, M. D.
    Benza, R. L.
    Badesch, D. B.
    Giles, S.
    Feldkircher, K.
    Miller, D. P.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 518 - 518
  • [12] Long-term survival in pulmonary arterial hypertension: the REVEAL registry
    Benza, R. L.
    Miller, D. P.
    Barst, R. J.
    Badesch, D. B.
    Frost, A. E.
    McGoon, M. D.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 676 - 676
  • [13] Long-term survival in pulmonary arterial hypertension: the REVEAL registry
    Benza, R. L.
    Miller, D. P.
    Barst, R. J.
    Badesch, D. B.
    Frost, A. E.
    McGoon, M. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 676 - 676
  • [14] Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management
    Shapiro, Shelley
    Traiger, Glenna L.
    Turner, Michelle
    McGoon, Michael D.
    Wason, Prieya
    Barst, Robyn J.
    [J]. CHEST, 2012, 141 (02) : 363 - 373
  • [15] Predictors Of Five-Year Outcomes In Patients With Pulmonary Arterial Hypertension
    McGoon, M. D.
    Frost, A. E.
    Miller, D. P.
    Barst, R. J.
    Elliott, C. G.
    Farber, H. W.
    Benza, R. L.
    Poms, A.
    Feldkircher, K.
    Badesch, D. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [16] Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey
    Burger, Charles D.
    Foreman, Aimee J.
    Miller, Dave P.
    Safford, Robert E.
    McGoon, Michael D.
    Badesch, David B.
    [J]. MAYO CLINIC PROCEEDINGS, 2011, 86 (02) : 105 - 112
  • [17] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [18] Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
    Farber, Harrison W.
    Miller, Dave P.
    Poms, Abby D.
    Badesch, David B.
    Frost, Adaani E.
    Muros-Le Rouzic, Erwan
    Romero, Alain J.
    Benton, Wade W.
    Elliott, C. Gregory
    McGoon, Michael D.
    Benza, Raymond L.
    [J]. CHEST, 2015, 148 (04) : 1043 - 1054
  • [19] Long-term outcomes in pulmonary arterial hypertension
    Thenappan, T.
    Palevsky, H. I.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 : 42 - 44
  • [20] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345